BerandaTWST • NASDAQ
add
Twist Bioscience Corp
$43,65
Setelah Jam Perdagangan Normal:(0,00%)0,00
$43,65
Tutup: 21 Jan, 16.11.21 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$41,65
Rentang hari
$41,30 - $44,15
Rentang tahun
$23,30 - $55,33
Kapitalisasi pasar
2,67Â M USD
Volume Rata-Rata
1,23Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 99,01Â jt | 16,88% |
Biaya operasional | 80,77Â jt | 8,74% |
Penghasilan bersih | -27,14Â jt | 21,69% |
Margin laba bersih | -27,41 | 33,00% |
Penghasilan per saham | -0,45 | 23,73% |
EBITDA | -26,83Â jt | 16,12% |
Tarif pajak efektif | -0,96% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 232,43Â jt | -15,91% |
Total aset | 641,86Â jt | 4,48% |
Total liabilitas | 168,90Â jt | 19,25% |
Total ekuitas | 472,96 jt | — |
Saham yang beredar | 61,15 jt | — |
Harga terhadap nilai buku | 5,34 | — |
Tingkat pengembalian aset | -11,64% | — |
Tingkat pengembalian modal | -13,19% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -27,14Â jt | 21,69% |
Kas dari operasi | -11,81Â jt | 22,89% |
Kas dari investasi | -12,40Â jt | -865,21% |
Kas dari pembiayaan | 5,57Â jt | 53,68% |
Perubahan kas bersih | -18,48Â jt | -43,20% |
Arus kas bebas | -14,59Â jt | -124,74% |
Tentang
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Didirikan
2013
Situs
Karyawan
979
